Lundbeckfond Invest A/S 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-01-26 4:15 pm Unchanged |
2021-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Lundbeckfond Invest A/S | 1,151,544 4.500% |
0 (Unchanged) |
Filing |